CTC

Executive Summary

CTC (Clinical Trial Consultants) is a Swedish full-service Contract Research Organization (CRO) specializing in early-phase clinical trials, from Phase 0 through Phase II and medical device studies. Founded in 2001 and headquartered in Gothenburg, the company differentiates itself through a unique network of seven state-of-the-art research clinics across Sweden and the Netherlands, including a dedicated First-in-Human (FIH) unit. This in-house infrastructure enables CTC to offer accelerated timelines, rigorous patient safety monitoring, and seamless data collection, positioning it as a preferred partner for biotech and pharmaceutical sponsors seeking high-quality early-phase development services. The company's focused expertise in oncology and cell therapy further enhances its competitive edge in the CRO market.

Upcoming Catalysts (preview)

• Q4 2026Expansion of Clinic Network into New European Markets75% success
• Q3 2026Major Multi-Year Contract with Top-20 Pharma for FIH Studies60% success
• Q1 2027Launch of Specialized Cell Therapy Trial Unit80% success